Literature DB >> 3160710

Excitatory 5-hydroxytryptamine receptors in the cat urinary bladder are of the M- and 5-HT2-type.

P R Saxena, J Heiligers, E J Mylecharane, R Tio.   

Abstract

In anaesthetized cats, a biphasic contraction of the urinary bladder, consisting of an initial spike followed by a longer-lasting contracture, was elicited by 5-hydroxytryptamine (5-HT) in doses of 3-30 micrograms/kg, i.a. Administration of MDL 72222 (30, 100 and 300 micrograms/kg, i.v.), which specifically antagonizes the M-type 5-HT receptors, selectively blocked the spike phase of the 5-HT response. Ketanserin (30, 100 and 300 micrograms/kg, i.v.), on the other hand, eliminated only the second phase of the 5-HT-induced bladder contraction. Injection of MDL 72222 (300 micrograms/kg) after ketanserin (300 micrograms/kg), or of 100 micrograms/kg of methysergide or cyproheptadine, or 300 micrograms/kg of ketanserin after MDL 72222 (300 micrograms/kg), led to blockade of both phases of the response to 5-HT. The contractile response to dimethylphenylpiperazinium (DMPP) remained unaffected. These results clearly show that the early and late phases of the cat urinary bladder contraction elicited by 5-HT are mediated by M and 5-HT2 receptors, respectively.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3160710     DOI: 10.1111/j.1474-8673.1985.tb00110.x

Source DB:  PubMed          Journal:  J Auton Pharmacol        ISSN: 0144-1795


  10 in total

1.  Analysis of the heart rate effects of 5-hydroxytryptamine in the cat; mediation of tachycardia by 5-HT1-like receptors.

Authors:  P R Saxena; E J Mylecharane; J Heiligers
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-08       Impact factor: 3.000

2.  Evidence for the presynaptic action of 5-hydroxytryptamine and the involvement of purinergic innervation in the rabbit lower urinary tract.

Authors:  H I Chen
Journal:  Br J Pharmacol       Date:  1990-09       Impact factor: 8.739

3.  Neural 5-HT4 receptors in the human isolated detrusor muscle: effects of indole, benzimidazolone and substituted benzamide agonists and antagonists.

Authors:  S M Candura; E Messori; G P Franceschetti; G D'Agostino; D Vicini; M Tagliani; M Tonini
Journal:  Br J Pharmacol       Date:  1996-08       Impact factor: 8.739

4.  Effects of MDL 72222 and methiothepin on carotid vascular responses to 5-hydroxytryptamine in the pig: evidence for the presence of "5-hydroxytryptamine1-like" receptors.

Authors:  P R Saxena; D J Duncker; A H Bom; J Heiligers; P D Verdouw
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-07       Impact factor: 3.000

5.  5-Hydroxytryptamine-induced tachycardia in the pig: possible involvement of a new type of 5-hydroxytryptamine receptor.

Authors:  A H Bom; D J Duncker; P R Saxena; P D Verdouw
Journal:  Br J Pharmacol       Date:  1988-03       Impact factor: 8.739

6.  Serotonin and the Australian connection: the science and the people.

Authors:  Ewan J Mylecharane
Journal:  ACS Chem Neurosci       Date:  2013-01-16       Impact factor: 4.418

7.  5-Hydroxytryptamine receptors that facilitate excitatory neuromuscular transmission in the guinea-pig isolated detrusor muscle.

Authors:  E Messori; C A Rizzi; S M Candura; A Lucchelli; B Balestra; M Tonini
Journal:  Br J Pharmacol       Date:  1995-06       Impact factor: 8.739

8.  Evidence for an inhibitory 5-HT4 receptor in urinary bladder of rhesus and Cynomolgus monkeys.

Authors:  M V Waikar; A P Ford; D E Clarke
Journal:  Br J Pharmacol       Date:  1994-01       Impact factor: 8.739

9.  Activation of 5-HT3 receptor subtypes causes rapid excitation of rabbit parasympathetic neurones.

Authors:  T Akasu; H Hasuo; T Tokimasa
Journal:  Br J Pharmacol       Date:  1987-07       Impact factor: 8.739

10.  5-hydroxytryptamine induced relaxation in the pig urinary bladder neck.

Authors:  Paz Recio; María Victoria Barahona; Luis M Orensanz; Salvador Bustamante; Ana Cristina Martínez; Sara Benedito; Albino García-Sacristán; Dolores Prieto; Medardo Hernández
Journal:  Br J Pharmacol       Date:  2009-03-20       Impact factor: 8.739

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.